There are often discussions and debates about various indicators and trends that supposedly signal the beginning or end of bull markets. One popular notion that has gained traction on social media platforms like Twitter is the idea that bull markets start with a Pharma Rally and end with a PSU Rally. However, it is essential to dispel this myth and examine the facts rather than relying on narratives and rumours. In this blog, we will present an analysis of the Pharma Index (Nifty PHARMA) and public sector enterprise (NIFTY PSE) stocks to shed light on the reality of these claims.
Case a – PHARMA Index
The first claim we will explore is the assertion that Pharma stocks lead bull markets. To assess the validity of this statement, let us examine the historical data of the Pharma Index. From 2003 to 2008, the Pharma Index experienced a substantial rally, indicating a bullish phase. However, this rally came to an abrupt halt due to the Global Financial Crisis (GFC) in 2008, causing a significant disruption in the market.
Case b – PSE Index
The second claim we will analyze is the notion that PSU stocks indicate the end of bull markets. To evaluate this assertion, let us delve into the historical performance of PSU stocks. From 2001 to 2008, PSU stocks experienced a significant bull run clocking a remarkable 15x in 7 years. However, after 2007, PSU stocks failed to regain their previous momentum.
Only in recent years, with the rally witnessed in April 2023, have PSU stocks started showing signs of improvement. As of now, PSU stocks have only surpassed the previous highs achieved in 2008 by a marginal 20% to 25%. This suggests that PSU stocks are just entering a bull market phase and do not indicate the termination of a bull market, contradicting the claim that a PSU rally signifies the end of a bull market.
Focus on Strategy Over Narratives
It is crucial for investors and market participants to exercise caution when it comes to narratives and rumours circulating on social media platforms. These narratives may sound persuasive and may even come from well-followed accounts, but it is vital to base investment decisions on concrete data and analysis rather than mere speculation.
As an experienced market observer with nearly three decades of experience, I can assert that following narratives without a sound strategy can lead to misguided investments and potential loss of capital. Instead of getting swayed by these narratives, it is imperative to focus on developing a solid investment strategy that aligns with your financial goals and risk tolerance.
In conclusion, the claims that bull markets start with a Pharma Rally and end with a PSU Rally are unfounded. The analysis of the Pharma Index and PSU stocks reveals that Pharma stocks have not been in a sustained bull run for the past eight years, dispelling the notion that a Pharma rally signifies the beginning of a bull market. Additionally, PSU stocks are just starting to enter a bull market phase and cannot be considered reliable indicators of a market’s end.
As an investor, it is crucial to approach the market with a level-headed mindset and rely on thorough analysis rather than succumbing to narratives and rumours. Developing a well-thought-out investment strategy and staying informed about market fundamentals will ultimately yield better results than following speculative claims. Remember, investing requires a disciplined approach, and success is derived from careful consideration and analysis of data.
So, the next time you encounter claims about Pharma stocks leading a bull market or PSU stocks indicating its end, take a step back, examine the facts, and make informed decisions based on your own research and analysis.
Download the WeekendInvesting App
If you have any questions, please write to us on email@example.com